Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

The Nomination Committee's proposal to the Board prior to the 2022 Annual General Meeting includes a key player in the diabetes market

The Nomination Committee of Brighter AB (publ) proposes Johnny Ludvigsson, one of the world's top ten experts and researchers on type 1 diabetes, as a new board member of Brighter AB. Johnny Ludvigsson is a Swedish doctor and professor of pediatrics at Linköping University, chief physician at the Children and Women's Center at the University Hospital in Linköping and founder of the Child Diabetes Foundation. With his worldwide network of contacts and extensive experience and expertise, Ludvigsson is expected to be a significant asset for Brighter in its continued work to create solutions

Metsä Board’s co-creation workshop results in an innovative insect hotel

Metsä Board Corporation press release 9.2.2022Finnish Golf Coat Oy is launching a new golf ball packaging that, when empty, takes on a second life as an insect hotel. The innovative packaging is a result of a co-creation workshop organised by Metsä Board, part of Metsä Group. The workshops are part of Metsä Board’s 360 Services that cover the whole packaging value chain by utilising the state-of-the-art Excellence Centre in Äänekoski, Finland. The design of the golf ball packaging was a collaboration involving a packaging design agency, Metsä Board's own packaging design team, the packaging

Attana and AroCell initiates discussion for collaboration

Attana can today announce that the company has initiated a discussion about a new collaboration with the in vitro diagnostics company AroCell AB (Publ).AroCell AB is a Swedish company that develops and markets blood and urine sample tests and specializes in oncology and bacteriology. The company has a broad product portfolio that is used in healthcare and is established in various markets. The collaboration aims to exchange valuable knowledge in quality and product development, while AroCell's biomarkers can eventually be used on Attana's instruments. Teodor Aastrup, CEO Attana comments:

instagrid: The Expert for Mobile High-Performance Battery Systems Raises 33 Million U.S. Dollars

· Instagrid, the Ludwigsburg-based off-grid battery expert, raises $33 million in a Series B financing round · The technology offers mobile power supply from renewable sources that is entirely disconnected from the power grid · Climate tech investor Energy Impact Partners led the financing round · This funding will drive the international expansion of the company and the development of new, scalable business modelsLudwigsburg, 09.02.2022 - instagrid , a leader in high-performance mobile battery systems in the professional sector,  announced today its Series

Silenta Extreme wins "Innovative Product Award" at the Golden Plumb International Building Catalog Awards

GF Hakan Plastik has been awarded the "Innovative Product in Construction Building Catalog Special Award" for its GF Silenta Extreme piping system at the 27[th] annual "Golden Plumb International Building Catalog Awards" organized by YAPI KATALOĞU.YAPI KATALOĞU is Turkey's first and only material catalog that has been in publication since 1973. Their Golden Plumb International Awards ("ALTIN ÇEKÜL Uluslararası Yapı Kataloğu Ödülleri") were given out in three main categories: for innovative products, legal ideas and industry marketing.  GF Hakan Plastik has been providing top-quality

Reltime – Just received their crypto license for the PoA BaaS platform

Oslo, Norway, Feb. 9, 2022 -- Reltime PoA BaaS Ecosystem just received their crypto license in El Salvador to be able to hold digital assets for their client.Reltime.com, a Norwegian and Salvadorean-based challenging BaaS provider is the first of its kind to accomplish that status, what now is “textually considered” a Bitcoin provider for the Republic of El Salvador in the registry of The Central Bank of El Salvador. Reltime is very bullish and supportive of the movement of El Salvador.  The Regulations of the Law establishes that Reltime has license to provide for itself or for third

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 35 - 9 FEBRUARY 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

Complement: RhoVac plans for a fully guaranteed convertible loan rights issue, to finance activities following a successful clinical phase IIb study outcome

Complement: appendix added to previous release. RhoVac AB (”RhoVac”) announces today, February 9, 2022, that the Board of Directors intends to decide on execution of a preferential rights issue of a convertible loan (“the Planned Offer”) of approx. 25 M SEK in March/April 2022. The Planned Offer is via written agreement fully guaranteed, free of charge, by RhoVac’s largest shareholder M2 Asset Management AB. The objective of the Planned Offer is to further ensure that the company, given positive primary outcome results of the study, has the proper financial strength to negotiate and conclude

Selvaag Bolig ASA: Invitation to presentation of fourth quarter 2021 results

Selvaag Bolig ASA will publish its fourth quarter 2021 results Tuesday 15 February at 07:00 am CET. The quarterly report and the presentation materials will be available on the company's website, www.selvaagboligasa.no/en and www.newsweb.no, as well as news wires. CEO Sverre Molvik and CFO Christopher Brunvoll will present the company's results at 08:30 am CET at Høyres Hus, Stortingsgaten 20 in Oslo. A light breakfast will be served from 08:00. The presentation will be held in Norwegian and transferred via live webcast. Link to the webcast. 

Irisity recruits Johan Höglund as new CGO.

Irisity AB (publ), leading AI video analytics provider, continue to strengthen its management with the appointment of Johan Höglund as Chief Growth Officer, CGOAccelerating our international expansion, with ever larger global deals and partnerships, the appointment of Johan Höglund now strengthen our business development capabilities and growth. “Johan Höglund is a well-recognized and accomplished senior level professional, with an impressive track record of constantly delivering results. He now brings this experience to Irisity, being well suited overseeing our continued rapid growth”,

AFRY to design sustainable textile fibre biofactory for Altri in Spain

Altri has awarded AFRY engineering, site selection and integrated environmental authorization services assignment for a greenfield textile fiber factory in Spain. In addition, AFRY will support Altri to conceive, create and implement foundations for Industry 4.0 technologies in this new plant.The demand for sustainable textile fibres is growing quickly globally. To support this growth, the Portuguese pulp producer Altri has become the industrial partner to public-private consortium Impulsa (Society for the Development of Strategic Projects of Galicia) as the lead investor and technologist

Qt framework used for the development of Stellantis’ newly launched in-vehicle HMI

Qt has been selected to add 3D effects and enhance the human-machine interface across its portfolio of iconic European automotive brands.Espoo, Finland – 9[th] February 2022 – The Qt Company , the leading global provider of software technology, announces that Stellantis , the global automaker and provider of innovative mobility solutions works with Qt for the development of their current in-vehicle HMI systems across its portfolio of iconic European car brands. The project, which began in 2018, will see the Qt technology used for the

DanCann Pharma A/S has submitted application to the Danish Medicines Agency for EU-GMP-approval for Biotech Pharm1

COPENHAGEN, Denmark, 9 February 2022 – DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”), a Danish company powered by cannabinoids, hereby announce that the Company submitted its application for EU-GMP-approval to the Danish Medicines Agency.In April, DanCann Pharma pressed the start button in the Company’s first production facility, Biotech Pharm1 in Ansager. Now the Company is ready to be inspected from the Danish Medicines Agency in order to be approved according to EU-GMP standards. The approval is expected to be in place by the half year of 2022. Biotech Pharm1 is

Invitation to presentation of Embracer Group’s Q3 report

Embracer Group hereby invites you to a presentation in connection with the publication of the interim report for the third quarter, the period October-December 2021. The report will be published at 06.00 (CET) on February 17th and available as of this time at: www.embracer.comThe presentation will be held in English by CEO Lars Wingefors and CFO Johan Ekström, and afterwards a Q&A session will follow, led by analyst Oscar Erixon from Carnegie. Date:           February 17, 2022 Time:          09:00 CET Location:     Karlstad CCC, Tage Erlandergatan 8, Karlstad Online:

Mandatory notification of trade

On February 8, primary insiders in Atea ASA completed the following transactions. Robert Giori sold 83,400 shares and entered a contract to purchase 83,660 shares. Robert Giori sold 83,400 shares at an average price of 140.15.  On the same day, he exercised 100,000 stock options in the company at an average strike price of NOK 92.00.  Following withholding of income taxes, he acquired 83,660 shares in the company through the exercise of options.  The shares will be transferred on February 9. After the transactions, Robert Giori owns 126,587 shares together with close associates, and

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The share buy-back

RhoVac plans for a fully guaranteed convertible loan rights issue, to finance activities following a successful clinical phase IIb study outcome

RhoVac AB (”RhoVac”) announces today, February 9, 2022, that the Board of Directors intends to decide on execution of a preferential rights issue of a convertible loan (“the Planned Offer”) of approx. 25 M SEK in March/April 2022. The Planned Offer is via written agreement fully guaranteed, free of charge, by RhoVac’s largest shareholder M2 Asset Management AB. The objective of the Planned Offer is to further ensure that the company, given positive primary outcome results of the study, has the proper financial strength to negotiate and conclude optimally on the clinical phase IIb study follow-

BioStock: Evaxion Biotech publishes EVX-01 data in scientific journal OncoImmunology

This past decade has seen the rise of immunotherapies for the treatment of cancer, in many ways revolutionising this enormous treatment field. Danish Evaxion Biotech aims at pushing this development even further with its AI-powered personalised approach. The company recently published results from an ongoing phase I/IIa clinical study with lead drug candidate EVX-01 in the open access, peer-reviewed clinical journal OncoImmunology.Read the full article at biostock.se:https://www.biostock.se/en/2022/02/evaxion-biotech-publishes-evx-01-data-in-scientific-journal-oncoimmunology/This is a

Notice of extraordinary general meeting in NeoDynamics AB

The shareholders of NeoDynamics AB (publ), reg. no. 559014-9117 (the “Company”) are hereby convened to the extraordinary general meeting on Friday 25 February 2022 at 09.00 at the Company’s premises at Lejonvägen 14, Lidingö. Information regarding Covid-19 The Company takes the current Covid-19 situation very seriously and therefore urges all shareholders to carefully consider whether a personal / physical presence at the meeting is necessary and to consider the alternative of attending the general meeting through a proxy instead. Shareholders with cold or flu-like symptoms, including

CLS and Skåne University Hospital enter a clinical trial agreement to evaluate MR-guided Laser Interstitial Thermal Therapy (LITT) for glioblastoma ablation

Clinical Laserthermia Systems AB (publ) (CLS), which develops advanced innovative products for high-precision image guided laser ablation, announces that it has entered into an agreement with Skåne University Hospital  to sponsor a clinical trial evaluating the safety and feasibility of magnetic resonance (MR) guided laser interstitial thermal therapy (MRgLITT) for ablation of glioblastoma lesions, using the CLS TRANBERG® Thermal Therapy System with Thermoguide™ Workstation. Approval for this trial has been obtained from the Swedish Medical

TF Bank: Monthly statistics January 2022

The total loan portfolio amounted to SEK 11,181 million at the end of January. Compared to January 2021, the loan portfolio has increased by 32 % in local currencies.  Month Jan-22 Jan-21 ChangeConsumer Lending   New lending, SEK million 411 320 28 %Ecommerce Solutions   Transaction volume*, SEK million 588 293 101 %Credit Cards   New lending, SEK million 256 126 103 % *The sum of all purchases that goes through TF Bank’s payment solutions All figures for January 2022 are preliminary. For

Cereno Scientific publishes year-end report for 2021 (1 January – 31 December)

The Board and Chief Executive Officer of Cereno Scientific AB here presents the year-end report for the year 2021. Summary of the year-end report, January – December 2021Cereno Scientific Group Full year (1 January – 31 December 2021) · Net Sales were SEK 0 (0) · Result after financial items was SEK -16,254,890 (-16,017,958) · Earnings per share was SEK -0.15 (-0.22) before dilution and SEK -0.11 (-0.21) after dilution · The equity/assets ratio was 94.1% (88.9%) · Cash and bank balance was SEK 89,634,757 (66,004,352) Fourth quarter (1 October – 31 December 2021)

SCA appoints new CFO

SCA has appointed Andreas Ewertz as its new CFO. Ewertz has worked at SCA since 2017, where he has been responsible for investor relations and served as head of business control for business areas Publication Paper and Pulp, respectively.Ewertz, who will become a member of SCA group management, will take up the position as CFO on May 1, 2022. Prior to his employment at SCA, Ewertz worked in a number of different roles at Handelsbanken Capital Markets. Ewertz, born in 1987, holds a Master’s degree in Industrial Engineering and Management from Linköping University. Ewertz replaces current

Nel ASA: Invitation to presentation of Q4 2021 results

(Oslo, 9 February 2022) Nel ASA will announce its fourth quarter 2021 report on Wednesday 16 February at 07:00 CET and will host a presentation at 08:00 CET. The presentation will be held at Hotel Continental, Oslo at 08:00 CET. The presenter will be Jon André Løkke, CEO. The presentation will be followed by Q&A based on submitted questions during the call. The presentation will be broadcasted live at www.nelhydrogen.com and can also be streamed at https://channel.royalcast.com/landingpage/hegnarmedia/20220216_5/. As Covid-19 restrictions are lifted in Oslo, physical participation is

There are no items matching the current filter
There are no more items matching the current filter
Back to top